Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy
Bonechi, Martina, Galardi, Francesca, Biagioni, Chiara, De Luca, Francesca, Bergqvist, Mattias, Neumüller, Magnus, Guarducci, Cristina, Boccalini, Giulia, Gabellini, Stefano, Migliaccio, Ilenia, Di LeVolume:
9
Language:
english
Journal:
Oncotarget
DOI:
10.18632/oncotarget.24700
Date:
March, 2018
File:
PDF, 2.07 MB
english, 2018